Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alison W Loren

Showing results (21-30 of 122) with videos related to

Pageof 13
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|January 8, 2014
Development of lymphomas containing Epstein-Barr virus after therapy with hyper-CVAD regimenMarlise R Luskin, Darshan B Roy, Mariusz A Wasik, et al.
Transplantation and Cellular Therapy|January 5, 2024
Chronic Graft-versus-Host Disease-Associated Muscle Cramps: Severity and Response to Immunomodulatory TherapiesSupriya Rastogi, Ellen J Kim, Joel M Gelfand, et al.
Journal of the American Academy of Dermatology|February 1, 2026
Correction to Chronic graft-versus-host disease. Part I: Epidemiology, pathogenesis, and clinical manifestations [Journal of the American Academy of Dermatology 2024 Jan;90(1)1-16]Emily Baumrin, Alison W Loren, Sandy J Falk, et al.
Journal of the American Academy of Dermatology|December 26, 2022
Chronic graft-versus-host disease. Part I: Epidemiology, pathogenesis, and clinical manifestationsEmily Baumrin, Alison W Loren, Sandy J Falk, et al.
Journal of the American Academy of Dermatology|December 26, 2022
Chronic graft-versus-host disease. Part II: Disease activity grading and therapeutic managementEmily Baumrin, Alison W Loren, Sandy J Falk, et al.
Journal of the American Academy of Dermatology|February 1, 2026
Correction to Chronic graft-versus-host disease. Part II: Disease activity grading and therapeutic management [Journal of the American Academy of Dermatology 2024 Jan;90(1)19-36]Emily Baumrin, Alison W Loren, Sandy J Falk, et al.
Archives of Dermatology|September 21, 2011
Congestive heart failure in a patient with cutaneous T-cell lymphoma treated with low-dose interferon alfa-2bKatherine G Evans, Alison W Loren, Alain H Rook, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|January 20, 2004
Derivation of malignancy status from ICD-9 codesMark G Weiner, Alice Livshits, Carol Carozzoni, et al.
JAMA Network Open|November 9, 2020
Association of Racial/Ethnic and Gender Concordance Between Patients and Physicians With Patient Experience RatingsJunko Takeshita, Shiyu Wang, Alison W Loren, et al.
Leukemia & Lymphoma|December 11, 2012
Characteristics and outcome of acute myeloid leukemia in patients with a prior history of autoimmune diseaseCourtney D DiNardo, Alexis Ogdie, Elizabeth O Hexner, et al.
Pageof 13

Showing results (21-30 of 122) with videos related to

Sort By:
Pageof 13
Clinical Lymphoma, Myeloma & Leukemia|January 8, 2014
Development of lymphomas containing Epstein-Barr virus after therapy with hyper-CVAD regimenMarlise R Luskin, Darshan B Roy, Mariusz A Wasik, et al.
Transplantation and Cellular Therapy|January 5, 2024
Chronic Graft-versus-Host Disease-Associated Muscle Cramps: Severity and Response to Immunomodulatory TherapiesSupriya Rastogi, Ellen J Kim, Joel M Gelfand, et al.
Journal of the American Academy of Dermatology|February 1, 2026
Correction to Chronic graft-versus-host disease. Part I: Epidemiology, pathogenesis, and clinical manifestations [Journal of the American Academy of Dermatology 2024 Jan;90(1)1-16]Emily Baumrin, Alison W Loren, Sandy J Falk, et al.
Journal of the American Academy of Dermatology|December 26, 2022
Chronic graft-versus-host disease. Part I: Epidemiology, pathogenesis, and clinical manifestationsEmily Baumrin, Alison W Loren, Sandy J Falk, et al.
Journal of the American Academy of Dermatology|December 26, 2022
Chronic graft-versus-host disease. Part II: Disease activity grading and therapeutic managementEmily Baumrin, Alison W Loren, Sandy J Falk, et al.
Journal of the American Academy of Dermatology|February 1, 2026
Correction to Chronic graft-versus-host disease. Part II: Disease activity grading and therapeutic management [Journal of the American Academy of Dermatology 2024 Jan;90(1)19-36]Emily Baumrin, Alison W Loren, Sandy J Falk, et al.
Archives of Dermatology|September 21, 2011
Congestive heart failure in a patient with cutaneous T-cell lymphoma treated with low-dose interferon alfa-2bKatherine G Evans, Alison W Loren, Alain H Rook, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|January 20, 2004
Derivation of malignancy status from ICD-9 codesMark G Weiner, Alice Livshits, Carol Carozzoni, et al.
JAMA Network Open|November 9, 2020
Association of Racial/Ethnic and Gender Concordance Between Patients and Physicians With Patient Experience RatingsJunko Takeshita, Shiyu Wang, Alison W Loren, et al.
Leukemia & Lymphoma|December 11, 2012
Characteristics and outcome of acute myeloid leukemia in patients with a prior history of autoimmune diseaseCourtney D DiNardo, Alexis Ogdie, Elizabeth O Hexner, et al.
Pageof 13